← Leaderboards
Alan Gordon Sutherland
L2 Diagnostics, Llc
$2,685,002
Attributed
$6,726,652
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,726,652 · 4
By mechanism
R01$5,623,473 · 1
R43$1,103,179 · 3
Top collaborators
- Ronald R Breaker5 shared
- Barbara I Kazmierczak5 shared
- Karen G. Anthony2 shared
Most similar at L2 Diagnostics, Llc
Same institution · by research overlap
- Michel Ledizet$12,357,647
- Karen G. Anthony$11,228,942
- Raymond A Koski$5,972,928
Others in their field
Top investigators on “Analog”
- David Heimbrook · Leidos Biomedical Research, Inc.$196,589,777
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Norman Wolmark · Nsabp Foundation, Inc.$51,982,954
- Robert Turner Schooley · University Of Colorado Denver$48,513,949
- Kenneth A Bloom · University Of Nebraska-Lincoln$46,979,168
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
AnalogPharmaceutical ChemistryMetabolismGrowthResistanceAffectMulti-Drug ResistanceAntimicrobialProgramsBacteriaAnti-Bacterial AgentsReportingCellsStructure-Activity RelationshipResponseSmall MoleculeValidationPathogenLigandsBaseInfectionAntibioticsLeadCellular Assay
Grant awards (9)
A Point of Care Test for Babesia microti$293,142
R43 · FY2025 · AI · contact PI
Exploiting Riboswitch Sensors to Reveal Antibiotics Uptake and Retention in Gram Negative Bacteria$1,047,570
R01 · FY2022 · AI
Exploiting Riboswitch Sensors to Reveal Antibiotics Uptake and Retention in Gram Negative Bacteria$1,090,845
R01 · FY2021 · AI
Exploiting Riboswitch Sensors to Reveal Antibiotics Uptake and Retention in Gram Negative Bacteria$1,114,844
R01 · FY2020 · AI
Development of A Narrow Spectrum Anti-Tubercular Agent$285,676
R43 · FY2020 · AI
Exploiting Riboswitch Sensors to Reveal Antibiotics Uptake and Retention in Gram Negative Bacteria$1,135,599
R01 · FY2019 · AI
Development of A Narrow Spectrum Anti-Tubercular Agent$299,661
R43 · FY2019 · AI
Exploiting Riboswitch Sensors to Reveal Antibiotics Uptake and Retention in Gram Negative Bacteria$1,234,615
R01 · FY2018 · AI
Sterculic Acid Analogs to Inhibit Macular Degeneration$224,700
R43 · FY2014 · EY · contact PI